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Abstract

Introduction

The biomineralization of bovine pericardium
(BP) heart valve bioprostheses was investigated by
simulation of the process under in vitro and in
vivo conditions. The nature and composition of
calcific deposits that formed in human heart valve
bioprostheses were compared with the mineral formed
on BP discs immersed in a calcifying medium or
subcutaneously implanted into Sprague-Dawley rats.
The early stage of experimental biomineralization
in vitro took place on the surface only, while in
vivo deposition appeared to be intrinsic, as
documented by histological cross sections. The
chemical composition of the initial mineral phase
formed under in vitro conditions had a mean molar
Ca/P ratio = 1.255, standard deviation (S.D.) =
0.057, (n = 6). The composition of mineral formed
under in vivo conditions had a low initial Ca/P
ratio. From 4 days to three weeks the average in
vivo ratio was 1.239, S.D. = 0.203 (n = 38). This
ratio increased to 1.707, S.D. = 0.038 (n = 6)
following seven weeks of implantation. The latter
ratio is similar to that of biomineral formed in
human bioprostheses: Ca/P = 1.645, S.D. = 0.021 (n
= 6).
The deproteinated biomineral showed a
population of microparticles in the range of 50-200
nm with a microcrystalline apatitic X-ray
diffraction pattern. The biomineral contained a
significant amount of carbonate, and the solubility
was markedly higher than the solubility of
Combined information from in
hydroxyapatite.
vitro, in vivo and bioprosthetic mineralization
supports the concept that octacalcium phosphate is
a precursor that transforms into bioapatite and is
implicated in the calcification of bioprosthetic
heart valves.

Surgical replacement of diseased natural
heart valves with bioprosthetic heart valves is a
very common and successful procedure in modern
cardiology.
Since 1960 when the first aortic
mitral valve was replaced [12], more than 600,000
patients have received valve substitutes [26].
Glutaraldehyde-pretreated bovine pericardium (BP)
is used to fabricate one type of heart valve
bioprosthesis.
Hilbert et al. [14] provided
detailed information of BP to be compared with
properties of other tissue derived biomaterials.
Prolonged application of BP and other tissuederived
bioprostheses
is
challenged
by
degeneration, predominantly (>60%) caused by
intrinsic
calcification
and
occasionally
accompanied by extrinsic calcification, the latter
arising from the ulceration of intrinsic deposits.
The sequence of events is well documented by Lev¥
et al. [21] and recent publications [26,27J
reporting and reviewing the problem of degeneration
of bioprostheses. The process of calcification of
tissue-derived biomaterials appears to be very
complex. At present there is no general mechanism
that takes into account all biomineralization
growth factors. Even the nature and identity of
calcific deposits (CD) are not well known. The
general consensus that CD is hydroxyapatite (HAP)
appears to be a gross oversimplication [30].
Nelson proposed a theory for formation of calcified
deposits in tissue based on in vivo mineralization
kinetic data [24] with special emphasis on
inhibitors.
The task of inhibition of
bioprosthetic calcification is very important, and
has been attempted with surfactants [4J, magnesium
chloride
[4],
1-hydroxy-ethylidene-1,1bisphosphonic acid (HEDP) [20] and phosphocitrate
[34J. The administration of inhibitors via a local
controlled-release system was more successful and
advantageous compared to injection therapy [21].
Calcification can be controlled and effectively
suppressed, but it may recur if the administration
of the inhibitor is discontinued or if the
inhibitor is depleted from the controlled-release
device. The controlled-release device has good
potential but apparently has a distinct time
limitation.
Therefore, the development of new
agents, especially formulations with longer
performance times, is desirable. Studies of the

Key words: Bioapatite,
bovine pericardium,
cardiovascular biomineralization, hydroxyapatite,
octacalcium phosphate, solubility.
*Address for correspondence:
B. B. Tomazic
ADAHF, Paffenbarger Research Center
National Institute for Standards and Technology
Building 224, Room A153
Gaithersburg, MD 20899
Phone No.: (301) 975 6827

231

B.B. Tomazic, C. Siew, and W.E. Brown

In v;vo mineralization.
The mineralization ;n v;vo was accomplishe~
by subcutaneous implantation of two lxl cm
segments of g l utara l dehyde-treated BP into the
dorsal walls of Sprague-Dawley rats (40 adult, 7week-old male rats, 200-225 g), which were kept on
a normal Purina diet.
The progression of
biomineralization was assayed at selected times,
After the
ranging from one day to 7 weeks.
sacrifice of the animals by overdose of
pentobarbital,
segments were retrieved and
characterized by chemical and microscopic methods.
Levi et al. [19] have shown that the implant
calcification is very extensive in young animals (3
weeks opposed to 8 months old). The supplied 7week-o l d rats were assumed to be at the proper
level of maturity to produce considerable implant
mineralization in the present study.

prevention of calcification are more likely to
facilitate this development, if the studies include
investigations on inhibition of the precursor phase
formation and its transformation to the final CD.
There is good evidence that octacalcium phosphate
(OCP) is a precursor in biomineral formation [2].
The aim of the present work is to provide qualitative information concerning this biomineralization process by analysis of CD formed under
different conditions. The proper identification of
precursor(s) and the inhibition of their formation
and transformation may be major steps to successful prevention of cardiovascular biomineralization.
Materials and Methods
Materials. 1
All solutions used in the present study were
prepared by dissolving reagent grade chemicals in
distilled water, followed by filtration of stock
solutions through a 0.8 µ,m Millipore membrane.
Bovine pericardium (BP) pretreated with and stored
in 0.625 vol % glutaraldehyde - 0.02 M KH 2P0 4
solution, pH= 7.40, was kindly provided by Baxter
Corporation, Irvine CA. The surgically explanted
bioprosthetic heart valves were preserved by
immersion in a formaldehyde medium.

Characterization of the mineralizing media and the
equilibrated solutions.
The mineralizing media were analyzed during
;n v;tro BP mineralization experiments. The
analytical data were used to calculate ionic
speciation and ionic activity products (IAPs) of
representative
calcium
phosphate
phases,
hydroxyapatite (HAP), octacalcium phosphate (OCP),
~-tricalcium
phosphate (TCP) and dicalcium
phosphate dihydrate (DCPD) with a previously
described computational procedure [29]. The pIAP
for calcium phosphate phases are defined as:

In v;tro mineralization.
The mineralization of glutaraldehyde-treated
BP jn vjtro was studied by jmmersing precut discs
with surface areas of 6.6 cm , fixed on a glass rod
frame, in a metastable solution containing calcium
chloride (2.3 - 2.5 mM), potassium hydrogen
phosphate (1.35 - 1.5 mM) and 0.15 M sodium
chloride. The pH of the solution was adjusted to
7.40 by the addition of 0.01 Mpotassium hydroxide.
The mineralization systems were ke~t in doublewalled, thermostated vessels (t=37 C) and purged
with water-saturated nitrogen gas to prevent
carbonate contamination.
The solutions also
contained 0.1% sodium azide to prevent bacterial
growth during prolonged mineralization of BP.
During the mineralization, the pH was held constant
by pH-stat addition of 0.01 Mpotassium hydroxide,
with a system consisting of a METROHM 632 pH meter,
a 614 Impulsomat and a 655 Dosimat (Brinkmann
Instruments).
The
progression
of
the
mineralization was followed by periodic sampling
and chemical analyses of the mineralizing solution
which was filtered through 0.22 µ,m Millipore
membrane.
Calcium and phosphate concentrations
were determined by atomic absorption (AA) and
molybdate vanadate spectrophotometric [9] methods,
respectively. BP discs were retrieved for chemical
analysis of the calcium phosphate deposition and
for microscopic examination.

pIAP{DCPD)

log (Ca 2+) (HPOt)

(1)

pIAP(OCP)

log (Ca 2+)4 (P0/) 3 (H+)

(2)

pIAP(TCP)
pIAP(HAP)

2

3

log (Ca +) (P0/)

2

log (Ca 2+) 5 (P0/) 3 (0W)

(3)
(4)

(The parentheses represent ionic activities).
The results define saturation conditions of the
mineralizing solution and the thermodynamic driving
force - AG for formation of the particular calcium
phosphate phase: - AG= RT ln IAP(X)/K 5 P.(X), where
X = DCPD, OCP, ~-TCP or HAP, and Ksp is the
thermodynamic solubility product of the calcium
phosphate phase. The same ca lcu lat ion procedure
was also used to estimate solubilities of
deproteinated calcific deposits isolated from
bioprosthetic heart valves after equilibration with
diluted mineral acid as described elsewhere [30].
Chemical analyses of calcific de posits.
A. Experimental mineralization. The mineral
formed on BP segments jn v ;tro was dissolved by
acid rinse. Individual segments were treated with
2 ml of 1 M HCl, 2 ml concentrated HCl or 2 ml
concentrated HN0 3 , respectively, as described in
Table 1.
The biomineral formed jn vjvo was
recovered by dissolving the individual implant in
10 ml of 6 MHCl. Aliquots of solute were diluted
with water to obtain 2 to 10 ppm Ca and P
conc entration range. Calcium and phosphate were
dete r mined by atomic absorption (AA) and visible
spec troscopy [9], respectively.
B. Bioprosthetic heart valve deposit. The
calc if ic deposit was carefully removed from

1

Certa in commercial materials and equipment
are identified in this paper to specify the
experimental procedure. In no instance does such
identification imply recommendation or endorsement
by the National Institute of Standards and
Technology or the ADA Health Foundation or that the
material or equipment identified is necessarily the
best available for the purpose.
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Table 1. Composition of mineral formed on BP discs.
after 16 hours mineralization in vitro.
Sample
#

µM Ca/g

depositedx

Ca

Six discs recovered, processed and analyzed

wt. of deposition (mg)
Ca+P04
P04

Ca+
P04 /cm2

Ca/P
molar
ratio

-------------------------------------------------------------------------------------------------D-1*
D-2*

246
112

0.492
0.222

0.882
0.451

1. 374
0.673

0.2082
0.1020

1. 32
1.17

D-1**
D-2**

230
86

0.460
0.173

0.891
0.328

1. 351
0.501

0.2047
0.0760

1.23
1.25

D-1***
D-2***

83
81

0.166
0.163

0.298
0.301

0.464
0.464

0.0703
0.0703

1. 24

Mean

139.7

0.279

0.525

0.804

0.1219

1.255

S.D.

77 .2

0.154

0.285

0.438

0.0665

0.057

1. 32

x = The µmoles Ca/g (g
dry weight of implant) and the molar Ca/P ratio of the deposits were
calculated after the initial content of Ca and P in segments were subtracted from the measured
values after dissolution of the BP implants. The average initial content was 120 µmoles Ca/g and
26 µmoles P/g (n=5).
*=mineral was dissolved in 1 M HCl (3 min vibromix shaking agitation); cc 95% of mineral was
recovered.
**=mineral was dissolved in concentrated HCl, followed by evaporation and oxidative decomposition
of protein residue with H202 ; cc 97% of mineral was recovered.
***=mineral was dissolved in concentrated HN03 , followed by evaporation and oxidative decomposition
of protein residue with H202 ; cc 98 % of mineral was recovered.
11

11

Morphology of mineral formed on BP segments
was examined by scanning electron microscopy (SEM)
(air dried, Au coated samples) with a JEOL JSM-5200
scanning electron microscope.
Deproteinated
bioprosthetic heart valve deposits were examined by
SEM for comparison with non-deproteinated deposits.
The in vitro formed mineral and heart valve
calcified deposits were characterized by polarizing
microscopy. Measurements of average refract ion
indices (R.I.) of microcrystalline materials were
performed by the immersion method with a Leitz
orthoplane research microscope.

explanted human bioprostheses and deproteinated by
hypochlorite treatment [38]. Two mg samples of CD
were dissolved by addition of 0.5 ml of 1 M HCl
followed by water dilution to 10 ml. Aliquots of
prepared solutes were additionally dilluted for
determination of Ca, Na and Mg contents by AA
and pho~phate content by spectrophotometry [9].
The HP0 4 - contents in the ;n vitro formed products
and in native bioprosthetic deposits were determined by a modification of the pyrolytic method of
Gee and Dietz [7]. The materials were pyrolyzed in
a vacuum ( 0 .1 t9rr) at 500°C over 24 h, and the
fraction of HP0 4 - was determined from the difference in absorbance between hydrolyzed and nonhydro lyzed samples. Carbonate content was determined by microtitration [5]. After deproteination,
the inorganic fraction was routinely characterized
by x-ray diffraction (XRD) and Fourier transform
infrared (FTIR) spectroscopy. The mineral grown on
BP segments in vitro was characterized by XRD for
comparison with cardiovascular deposits.
XRD
patterns were recorded with a Phillips automated
powder . diffractometer,
with CuKa radiation
operating at 40 kV and 25 mA. The powder patterns
were compared with the JCPDS values for OCP and HAP
[39].

Results
In vitro BP mineralization.
Bovine pericardium segments fixed on a glass
rod frame were placed in a metastable mineralizing
so 1ut ion supersaturated with respect to DCPD, OCP,
TCP and HAP. The typical starting total calcium
concentration, TCa, was 2.47 mM, Ca/P solution
ratio 1.66. The calculated pIAP (-log IAP) values
were 6.57, 44.50, 25.76 and 46.40, compared to pK~~
values 6.60 [10], 48.70 [35], 28.91 [11] and 58.oo
[23] for corresponding calcium phosphate phases.
The mineralization of BP started after an induction
period ranging from 2-15 hours, depending on
initial degree of supersaturation. Special care
had to be taken to avoid spontaneous precipitation
of calcium phosphate from the mineralizing media,
which
were highly supersaturated with three
ca lei um phosphate phases.
In the case of
spontaneous precipitation, rapid pH-stat KOH uptake
resulted and most of the precipitation occurred in

Microscopic characterization.
The spatial character of in vitro vs in vivo
experimental mineralization was demonstrated on
cross sections of paraffin embedded BP segments.
Location of
mineralization was
determined
microscopically by examination of histologic
sections of BP stained by von Kossa's method [22].
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a
Fig. 1. Histologic section of mineralized BP; a)
surface mineralization in vitro.

Fig. lb. Subsurface biomineralization in vivo.
Paraffin-embedded tissue, van Kossa stain.

Fig. 2. Scanning electron micrograph of mineral
formed in vitro on BP surface after 16 hours; a)
large plate-like crystals (minor fraction).

Fig. 2b.
fraction).

solution.
In this case the experiment was
terminated, because this study was concerned only
with mineralization associated with BP.
The
controllable mineralization of BP, without
spontaneous precipitation of calcium phosphate, was
characterized by a slow KOH uptake with a constant
pH=7.40 being maintained. The mineralization was
followed for up to five days. After a relatively
fast start, mineralization gradually slowed and
practically stopped after five days. Analyses of
the solution during the controllable BP
mineralization showed the same concentration
changes with or without filtration, indicating that
all calcium phosphate deposition was associated
with the BP. Fig. la, a histologic cross section
of van Kossa stained BP, indicates that the calcium
phosphate deposition occurred only on the surface
of the BP without penetration into the tissue. The
chemical compositions of the deposits formed at 16
hours (Table 1) show a remarkable constancy and the
Ca/P ratios were slightly lower than those for OCP

(1.33). The extent of surface mineralization was
highly variable. This variablity could have been
a consequence of heterogeneity of the BP surfaces
or uneven fluid dynamics during the mineralization
process. At a later reaction time (56 hours), the
Ca/P ratio increased to 1.42.
In another
experiment, performed at pH= 7.20, mineralization
was slower and practically stopped after 3 days.
The product grown in this case had a Ca/P ratio of
1.38 (76 hours). At this time, the pIAP values for
DCPD, OCP, TCP and HAP were 6.83, 45.76, 26.77 and
48.17,
indicating that the solution was
undersaturated in respect to DCPD, moderately
supersaturated in respect to OCP and TCP and
markedly supersaturated in respect to HAP. Table
1 shows that the described acid rinses successfully
removed 95-98% of the mineral content (the
remaining 2-5% was determined by additional rinsing
of BP with 1 MHCl or dissolving the yellow residue
after oxidative evaporation with Hi0 2 ). The data
shown in Table 1
represent important new
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Fig. 3. Scanning electron micrographs of mineral
formed in vitro on smooth serosal BP surface after
5 days.

Fig. 3b. Detailed surface morphology of
time-transformed product.

Fig. 4a. Scanning electron micrograph of native
bioprosthetic calcific deposit.

Fig. 4b. Bioprosthetic calcific product following
hypochlorite deproteination.

information
on
the composition of early
mi nera 1i zat ion product, which may repr.esent the
precursor phase in cardiovascular calcification.
The SEM rnicrographs of in vitro grown mineral
The
deposits are shown in Figs. 2 and 3.
mineralization took place on the smooth outflow
(serosal) and rough inflow (epipericardial) surface
of BP. These two host surfaces are strikingly
different [14], but the present observations did
not indicate that one surface was preferred to the
other as a growth site. The early deposit appeared
to be heterogeneous and showed a minor fraction of
large plate-like crystals resembling DCPD (Fig. 2a)
and a major fraction of smaller rosette-like
crystals, presumably OCP (Fig. 2b). The OCP
identification was made by comparison with a
crystallized calcium phosphate of similar
morphology, that has been positively identified as
OCP [13]. At a later stage, the morphology of the
surface mineral was markedly changed. As shown in
Fig. 3a, the smooth serosal surface was covered
with smooth spherical particles. These part icles
had the very fine "honey comb " surface str ucture

shown on Fig. 3b, indicating the hydrolytic
transformation of early deposits shewn in Figs.
2a-b. Similar time-dependent morphological changes
of calcium phosphate were observed in the course of
pH-controlled mineralization of demineralized
dentine [28].
The transient formation of OCP was documented
by chemical analyses (Table 1) and XRD (Fig. SA).
The XRD spectrum is complex, but the presence of a
weak 100 OCP reflection is in agreement with the
finding that OCP once formed and then hydrolyzed
into a more basic apatitic substrate OCPH [32].
Polarizing microscopy of in vitro grown materials
provided the following information: The material
is composed of several particle types.
Type 1:
Isotropic, gel-like matrix with
incipient crystallization, 0.15-15 µm needles
showing preferred orientation and having R.I.: N1
= 1.553 and N3 = 1.560. Material is soluble in
dilute HCl and by this description indicates DCPD.
However, complete absence of DCPD XRD pattern rules
out DCPD to be type 1 material.

11

11
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Type 2:
Grainy particles of amorphous
appearance with zonal overgrowth of colloform
from 1.575 to 1.585, but
banding, having R.I.
predominantly 1.585, comparable to the R.I. values
Apparently the grainy particles
for OCP [1] .
formed initially and then converted to a more
stable form (the 1.585 veneers) with time,
indicating transient formation of OCP.
Important new information was provided by
studying the phosphate species present in the in
vitro formed products and in native bioprosthetic
deposits, DC. f-Her pyrolysis, the determined
fraction of HP0 4 - in the in vitro grown product
(Fig. 3b) and the CD (Fig. 4a) was 8% and 12%,
respectively. These experimental data provi~ed
valid evidence of transient formation of HP0 4 - containing OCP followed by subsequent hydrolysis,
which takes place under given experimental
conditions [31] and presumably in maturing CD [2].
In vivo BP biomineralization.
The implants retrieved in the early stages of
the experiment (up to four days) were swollen. The
surrounding tissue appeared to be inf lamed. At a
later stage (after 7 days) the surgical wound had
healed resulting in 100% survival of the animals
prior to sacrifice. Histologic examination of 10
µm cross sections of BP implants retrieved after 7
weeks showed only subsurface calcification (Fig.
lb), in agreement with an earlier report [21]. The
charac te r of the progression of the biomineralization is shown in Table 2 and can be summarized as
follows: a) biomineralization started within 24
hours and the initial rate was very slow; b)
biomineralization was markedly accelerated after 4
days when the healing process had advanced; c) the

100

;/
7

17

37

27

47

TWO THETA (DEGREES)

Fig. 5. X-ray diffraction patterns of: (A) in
vitro formed products; (B) bioprosthetic calcific
deposit; (C) HAP; and (D) OCP [39].
Table 2.

In vivo biomineralization of subcutaneously implanted BP segments.

Residence
time( days)

Number of
implants

µmoles Ca/g
deposited*

S.D.

Ca/P
molar
ratio

S.D.

1. 9

0.65

0.05

---------------------------------------------------------------------------------------------------10
34.8
2

10

66.4

32.0

0.92

0.21

4

10

381. 2

124.9

1.20

0.07

7

10

1590.4

373.3

1.26

0.15

14

10

2111.8

468.3

1. 26

0.20

21

8

**

1. 24

0.35

35

8

**

1.86

0.27

49

6

**

1. 71

0.04

* The µmoles Ca/g (g = dry weight of implant) and the molar Ca/P ratio of the deposits were
calculated after the initial content of Ca and P in segments were subtracted from the measured
values after dissolution of the BP implants. The average initial content was 120 µmoles Ca/g and
26 µmoles P/g (n=5).
** = not determined on dry weight of implant basis.
Vertical bars define times at which Ca/P ratios of formed deposits were not significantly different
by Duncan s ranked multiple comparison procedure.
1
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Table 3. Chemical composition and solubility data of deproteinated bioprosthetic heart valve
deposits.
No.

G

A

BM

D

Ca

(case data)

M

Mg

Na

pIAP(OCP)*

(molar ratio)

pIAP(HAP)*

(weight)

42y

PV 15y

1.639

.0729

.0329

1.0

5.21

49.59

54.59

65y

PV

6y

1.647

.1175

.0297

1.0

5.85

49.58

54.63

21y

BP

2y

1.620

.1817

.0319

1.0

5.49

49.79

54.97

19y

PV

6y

1.672

.0713

.0381

1.0

6.25

49.20

54.14

33y

PV

lOy

1.634

.1290

.0240

1.0

N.D.

49.90

54.87

68y

PV

13y

1. 609

.0970

.0320

1.0

N.D .

50.01

55.07

Aver.

1.637

.1115

.0314

1.0

5.70

49.68

54.71

S.D.

0.022

.0415

.0046

.29

.29

.33

6

6

6

32

32

n obs.

6

9

G =gender (female or Male); A= age of recepient; BM = type of bioprosthetic material (PV or BP);
D = duration of implant.
* = Average pIAP values calculated from analytical data f rom five or six intependent equilibrations
of deproteinated deposits with diluted solutions for phosphoric acid under 5% C0 2/95% N2 stream;
48 hours, 37° C.

density of biomineralization varied greatly within
the same time implantation group; d) the Ca/P
ratios of formed mineral were found to be time
dependent and significantly different (p < 0.001,
ANOVA);
Duncan's ranked multiple comparison
procedure [ 37] showed that the Ca/P ratios were
significantly different for implantation times
shown in parentheses: (1), (2), (4,7,14,21) and
(35,49) days at p < 0.05; e) Ca/P ratios were low
for the early mineralization stage (from four days
to three weeks the Ca/P ratio was approximately
1.25, i.e. close to the OCP ratio); f) the final
Ca/P ratio = 1.71, S.D. = 0.04, close to aortic
biomineral [30].

substitution occuring in £-type carbonatecontaining bioapatite L29] had also taken place in
the bioprosthetic mineral. Table 3 provides the
solubility data for the listed deposits, expressed
as pIAP values.
These data clearly show that
deposits were less soluble than OCP and markedly
more soluble than HAP, since the average
A.
pIAP(OCP) (i.e., pIAP(OCP)-pKSJ'.>(OCP) = + 0.9 and
corresponding
A pIAP(HAP; = - 3.9.
As a
practical illustration of relative solubilities,
computer simulation showed that if equilibrium was
attained at pH 5.75, for a constant total phosphate
level of 1.9 mM, the total calcium level would be
3.0, 1.27 and 0.2 mM for OCP, #4 PV deposit and
HAP, respectively. If the dissolution of the three
materials
proceeded
congruently,
i.e.,
stoichiometrically as given by their chemical
compositions, the solubilities under the above
conditions would be 0.3348, 0.1355 and 0.0198 g/L,
These figures
excluding water of hydration.
provide solubility ratio for OCP : #4 PV deposit :
HAP of 16.91 : 6.82 : 1. In this way, the
solubility of the deposit can be properly compared
with two standards with known thermodynamic
properties [23,35].

Bioprosthetic heart valve deposits.
The morphology of retrieved native calcific
deposit is shown in Fig. 4a. After quantitative
deproteination by sonication in hypochlorite, the
morphology significantly changed from large
"crystals" to submicron particles, ranging from
50-200 nm in size (Fig. 4b). XRD patterns of this
material shown in Fig. Sb were of microcrystalline
apatite and practically identical to aortic
calcific deposits [30].
Chemical analyses of six bioprosthetic
deposits (Table 3) showed
that bioapatites
contained significant fractions of sodium,
magnesium and carbonate.
Comparisons of FTIR
spectra of deproteinated bioprosthetic heart valve
calcific deposits with aortic and total artificial
heart (TAH) deposits were practically identical,
indicating
that
the
carbonate/phosphate

Discussion
Calcific d~generation of tissue-derived
bioprostheses
is
a
special
case
of
biomineralization. By its complexity, the process
goes beyond present concepts of deposit formation
mechanisms and of solutions for practical
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prevention. The application of present results to
the understanding of the mineralization of
bioprosthetic heart valves may lead to more
rational solutions to severe heart insufficiency
problems. The present contribution aims to couple
basic information from jn vjtro and jn vjvo
biomineralization studies with information gained
directly from a physicochemical characterization of
In
actua 1 bi oprosthet i c heart valve deposits.
vjtro mineralization of BP at constant pH (Table 1)
shows that mineral with a low Ca/P ratio is formed
at an early stage, indicative of OCP. This finding
was also supported by SEM. The pH-stat controlled
crystallization practically stopped after three
days in spite of the fact that the solution medium
was moderately supersaturated with respect to OCP
and highly supersaturated to HAP. The fact that
growth did not proceed for the next two days
indicates stabilization of the precursor phase(s).
The slight increase in the Ca/P ratio at a later
reaction time perhaps resulted from slow hydrolytic
transformation of OCP to the more basic product
OCP-hydrolyzate (OCPH), in accordance with previous
Since precursor phase(s) were
findings L31].
kinetically favored, the present data do not
indicate direct growth of HAP. Koutsoukos et al.
[16] have shown that the direct precipitation of
HAP on the surfaces of collagen appeared to take
place under conditions where the growth medium was
supersaturated only with respect to HAP. At higher
supersaturation, OCP formation was indicated.
These findings are in agreement with the present
data despite the differences in the growth
surfaces. In the present and another independent
study [16], the onset of mineralization was
preceded by an induction period whose length
depended on the degree of OCP supersaturation. The
previously observed adsorption of phosphate on
collagen surfaces [15] may well take place on BP
surfaces. This was not directly documented in the
present study. The average Ca/P ratio of the
mineral formed after 16 hours of growth, 1.26, is
slightly lower than the ratio of 1.33 for OCP.
This may indicate absorption of phosphate prior to
Another nucleation
surface nucleation of OCP.
factor would be the surface of BP, which contains
many surface defects capable of interacting with
mineral-building ions. Mineralization under jn
vjtro conditions proceeds only on the surface of
BP, as shown on Fig. la.
This is crucially
different from jn vjvo biomineralization, which is
subsurface (Fig. lb). Consequently, additional
experimental work with animals is justified to
obtain realistic information about pathologic
biomineralization.
Mineralization of tissuederived bioprostheses has already been reported.
This phenomenon was discussed as being dependent on
biomaterial pretreatment [8] and compressive
mechanical deformations [3,33] that may affect
transport of mineral-forming species.
Table 2 provides quantitative data on the
progression of mineralization with special emphasis
on Ca/P composition of the forming mineral to
elucidate the nature of the precursor(s).
Preimplantation processing results in the loss of
the mesothelial cell layer [14] which may act as a
protective layer in cardiovascular tissue. This
may be a determining factor for rapid

biomineralization of BP implants in particular, and
calcific degeneration of BP bioprostheses in
general. After implantation, a thickening of the
The BP implants were
implants was observed.
swollen, which probably increased permeability and
thus facilitating more active ion diffusion. The
rates of diffusion of calcium and phosphate ions
through BP are not known. It is possible that
under these conditions, phosphate diffuses faster
than calcium, explaining the very low initial Ca/P
ratio (0.65). This does not necessarily mean that
the earlier precursor had a similar composition
because the formation of monocalcium phosphate
(Ca/P = 0.5) cannot occur under physiological
conditions. Another possible explanation for the
low Ca/P ratio is that preferential absorption of
phosphate on collagen was involved [15]. This
could provide a favorable site for nucleation.
After the surgical wound healed, the
consistency of the Ca/P ratio at 1.25 during three
weeks supports the proposed mechanism involving OCP
as the precursor in biomineral formation [2,30].
Remarkable agreement exists between the jn vjtro
and jn vjvo models, regardless of deposition site
and growth environment. Both processes took place
in media highly supersaturated with respect to HAP,
which did not form because OCP is kinetically
favored and _particularly in the presence of
magnesium ion L25]. An explanation for the absence
of pure HAP in cardiovascular biomineral [30] is
the presence of natural inhibitors in the serum
environment which apparently prevents direct HAP
formation [6]. The final 7-week residence product
has the ratio 1.71, suggesting that HAP had formed
by this time. The product may be apatitic, but it
more likely arose from the transformation of the
OCP precursor, either jn sjtu by solid state [l] or
by dissolution/precipitation [31] mechanisms
incorporating many different ions [32]. It should
be emphasized that biomineral is very different
from pure HAP in composition, structure, surface
and phys i cochemi cal properties.
The amount of
aqueous phase in the tissue is limited; therefore,
the transformation of a precursor probably proceeds
jn sjtu [2].
The basic considerations on the formation
mechanism
discussed
above
appear
to
be
substantiated with specific information on the
physicochemical properties of calcific deposits
isolated from heart valve bioprostheses. As shown
in Table 3, these materials can be represented as
sodium, magnesium and carbonate-substituted or
incorporated
apatite.
The
thermodynamic
solubilities of these materials are probably the
most important indication that a biomineral is
formed from a more soluble, presumably acidic
precursor. The biomineral is significantly more
soluble than HAP, ruling out this phase as a valid
representative of ca le if i c deposition. Another
indirect proof of this hypothesis is the striking
similarity in the physicochemical properties of
natural biominerals (Table 3) with material
prepared by hydrolysis of OCP in a sodium carbonate
medium (Ca/P=l.71,
Na/Ca=0.06 ratios, 6.4%
carbonate
content,
pIAP(OCP)=49.99,
pIAP(HAP)=54.96, and very similar XRD pattern and
infrared (i.r.) spectra L32]).
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At this point, we suggest that successful
suppression of biomineralization may involve: 1)
inhibition of the formation of precursors (i.e.,
inhibition of proliferation of calcified sites
[27]), and 2) inhibition of transformation (i.e.,
inhibition of crystal augmentation and nodule
confluence leading to clinical failure [27]). The
above two processes may take place at different
reaction rates which may be controlled with
different inhibitors.
It is well known that
magnesium
effectively
inhibits
hydrolytic
transformation of OCP [36] and may be a valid
candidate for controlling the second process.
Results of an earlier study support th ·is
proposition [18]. Therefore, the development of new
inhibitor formulations is a very important goal in
the practical application of this information. In
consideration of Mg as a practical inhibitor of
cardiovascu l ar biomineral i zation, facto r s such as
Mg homeostasis and toxicity must be critically
evaluated , and is a task for future studies.
Conclusions
The present data correlate information
obtained from the investigation of mineralization
of bovine pericardium segments, implants and
bioprosthetic heart valves. The composition of the
initial mineral
indicates that octacalcium
phosphate is a precursor in the genesis of
cardiovascular biomineralization.
The di stinct
difference between in vitro and in vivo processes
appears to be the mineralization site, BP surface
vs. BP subsurface mineralization. This finding
supports the validity of the animal model as being
the more realistic. Subsurface mineralization is
probably
facilitated
by
increased
tissue
permeability of swollen implants. The composition
and
physicochemical
characteristics
of
bioprosthetic calcific deposits support the
mechanism of formation via the OCP precursor. The
evidence of transient formation of OCP in
experimental calcification and during formation of
bioprosthetic calcific deposits was corroborated by
chemical, polarizing microscopy, structural and
thermodynamic solubility data. Solubilities of
deproteinated deposits are significantly higher
than the solubility of HAP and comparable to
This also supports the new
hydrolyzed OCP.
proposed mechanism of pa tho logic bi omi nera l i zat ion.
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Discussion with Reviewers
R. J. Levy:
Spontaneous precipitation is
men t ioned, and since this occurred, the frequency
of this occurrence should be noted since this would
pose an important experiment problem for anyone
attempting to duplicate these experiments.
Authors:
Spontaneous precipitation, which was
unfortunately over looked by some researchers, is
one possible drawback of in vitro mineralization
In answer to the question on
experiments.
frequency of this occurrence, to say 50% would be
an oversimplification, and the question cannot be
answered in such a manner.
The experimental
criteria for proving that only surface in vitro
mineralization takes place has been described in
detail sufficient to permit a careful experimentalist to distinguish the critical difference
between the two types of processes.
R. J. Levy:
The very low calcium phosphorous
ratios noted at 24 and 48 hours are inconsistent
with any mineral phase. In fact, the authors should
be aware of previous publications by others
demonstrating the onset of mineralization in this
model system occurring after 48 hours. This should
be discussed, especially since the authors feel
that their data are different in terms of
calcification actually occurring at 24 hours.
Authors: In case the determined blank value for
calcium shown in Table 2 was too high (120 µmoles
Ca/g), the corrected Ca/P ratio would be most
affected in the early stage (1 and 2 days). This
situation may be an explanation for the initial low
ratios (0.65 and 0.92) . Levy et al. [19] provided
data for calcium and phosphorous accumulation in
subcutaneously implanted glutaraldehyde-preserved
porcine aortic valves over a three-week period. The
authors concluded that the calcium phosphate ratios
were consistent with the predominance of hydroxyapatite. Our calculations based on reported average
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tissue calcium and phosphorous (µg/mg) levels [19]
show the molar Ca/P ratios of 1.56, 1.31, 1.36 and
1.36 for duration of 3, 7, 14 and 21 days,
respectively. This is in good agreement with our
present data covering a 4 to 21-day duration
period; both sets of data are consistent with the
predominance of octacalcium phosphate rather than
hydroxyapatite [19]. Only at a later stage, did
the ratio increase, the increase being consistent
with apatite formation by the proposed mechanism of
hydrolytic transformation of an OCP precursor [2].

polymers calcify similarly to glutaraldehyde fixed
tissue?
Authors:
TAH and bioprosthetic deposits were
practically identical based on FTIR spectroscopic
structural evidence. It would be premature
speculation to state that polymers, i.e.,
polyurethane, calcify similarly to glutaraldehyde
fixed tissue. However, the precursor(s) apparently
underwent a similar sequence of events to form
bioapatite, which incorporated carbonate and metal
ions, in accordance with the proposed mechanism of
hydrolytic transformation of an octacalcium
phosphate precursor [2, 32], additionally supported
by the presented in vitro and in vivo data.

F. Bilge: The main problem with this paper is its
inability to show the relationship between
in
vitro and in vivo calcification. The question, "Can
in vitro calcification be used to model fo vivo
calcification?" is not answered.
Authors: The question is very appropriate, and in
some respects it has been answered by stating that
in vivo data are more realistic because the mineral
deposition environment cannot be completely
duplicated in the in vitro runs.
The kinetic
factors are very dependent on the actual reaction
site and medium; therefore, the present data were
not intended to be used to compare the rates of the
two calcification processes.
However, the
relationship between the two processes can
illuminate very basic and essential questions on
the reaction mechanism and elucidation of
precursor(s)
in
pathologic
cardiovascular
calcification. Structural, chemical, solubility and
microscopic properties of materials formed in vitro
and in bioprosthetic deposits are very comparable
and therefore justify the propositions stated in
this paper about the relationship between the two
types of experimental calcifications.

F.M. Lupinetti: The authors have shown that the
chemical composition of early in vitro calcific
deposits are very similar to those of early in vivo
calcific deposits. However, there is a marked
difference in the location of the deposits surface
versus subsurface. How does the presence of blood
vessels surrounding the subcutaneous implant affect
the location of the calcium deposition?
Authors: We have no evidence that the presence of
blood vessels surrounding the subcutaneous implant
affects the location of the calcium deposition. The
demonstrated subsurface mineralization in vivo is
more likely attributable to necrotic tissue
containing dead cells whose surfaces and membrane
components can serve as suitable nucleating sites
for the deposition of diffusing inorganic
components from extracellular fluid. This situation
is comparable to crystallization in gels, which
allow slow diffusion of ions and the formation of
calcium phosphates, whose composition depends on
the physicochemical parameters of the gel medium
[17] . Once formed, the crystals can transform,
proliferate, and even penetrate through the tissue.
This is the most common case in advanced calcification of tissue-derived bioprosthetic devices.

F. Bilge: It is mentioned that calcific deposits
on TAH are identical to deposits on bioprosthetic
heart valves. Can this be interpreted to mean
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